Industry Insight Addressing One of the Most Common Dilemmas Faced by Oncologists Technology Networks spoke to Dr. Ofer Sharon, CEO of OncoHost, to learn about the challenges in non-small cell lung cancer treatment and how proteomics-based analysis could e
Technology Networks,
PD-1/PD-L1 immune checkpoint inhibitors have played a major role in revolutionizing cancer therapy.